TRODELVY (sacituzumab govitecan-hziy)

for the treatment of adult patients with Locally Advanced or Metastatic Breast Cancer.

• DOSAGE FORMS： For injection
• STRENGTHS： 180 mg lyophilized powder in single-dose vials for reconstitution
• Manufactured by： Gilead Sciences, Inc.
• ACTIVE INGREDIENT： sacituzumab govitecan-hziy